4th Global Genomic Medicine Collaborative Conference, Cape Town, South Africa

The 4th Global Genomic Medicine Collaborative Conference will be organized in Cape Town, South Africa, November 28-30, 2018.

The meeting will be organized by the Global Genomic Medicine Collaborative and the University of Cape Town as the local host and the Golden Helix Foundation, as G2MC partner. The 4th Global Genomic Medicine Collaborative Conference is the first to be organized in Africa, following the successful events in the United States in 2014, in Singapore in 2015 and in Athens in 2017 and will focus on the implementation of Genomic Medicine in low resource settings.

Leaders in Genomic Medicine across the globe will be attending this highly interactive meeting to define collaborative projects and strategies that will serve the global community to use genomic advances to improve clinical care. Representatives from the developed and the developing world will share challenges and strategies to overcome them. In addition we will be convening industry and leaders of large genomic consortia to engage in the dialog about the potential to impact health care delivery.

The 4th Global Genomic Medicine Collaborative Conference organizing Committee

Organized by:

 

Local organiser:                                  Organizing Partner:

Endorsed by:

The Global Genomic Medicine Collaborative

Overview

The Global Genomic Medicine Collaborative (G2MC) is an action collaborative among global leaders in the implementation of genomic medicine in clinical care. Arising from the 2014 Global Leaders in Genomic Medicine Summit, the purpose of G2MC is to identify opportunities and foster global collaborations for enabling the demonstration of value and the effective use of genomics in medicine. Engaging multiple stakeholders across the globe, the G2MC group, under the auspices of the Roundtable on Genomics and Precision Health, seeks to improve global health by catalyzing the implementation of genomic tools and knowledge into health care delivery globally. To accomplish these goals, seven working groups were created, including communications, education, evidence, IT/bioinformatics, pharmacogenomics, policy, and a steering group to guide and support efforts among working groups.

Specifically, it is intended to:

• Serve as nexus, clearinghouse, and knowledge base for genomic medicine activities globally;
• Develop opportunities for global genomic medicine demonstration projects (implementation and outcomes research) and;
• Capture and disseminate best practices for genomic medicine (in bioinformatics, education, evidence, pharmacogenomics, policy) across the global genomic medicine community.

 

Current Activities

The purpose and goals of the Global Genomic Medicine Collaborative (G2MC):

• Develop projects with global participation
  • Opportunities to disseminate learnings for genomic medicine implementation
  • Educational platforms to support genomic medicine projects
  • Community engagement and access to global genomic medicine expertise
• Creation of a registry or catalog of genomic medicine projects and programs across the globe to stimulate collaboration and efficiency in translation
• Be a global policy forum for genomic medicine
  • Mapping the global genomic medicine landscape particularly as it relates to policy and implementation
• Global eradication of preventable Stevens Johnson Syndrome/Toxic Epidermal Necrolysis

Previous Conferences 

3rd G2MC Conference; April 27-29, 2017, Athens, Greece – Implementing Genomic Medicine into Practice

The meeting objectives were to:

• Highlight national efforts and organizations around the world that are implementing genomic medicine into practice
• Foster collaborations to enable the implementation of genomic medicine
• Discuss public health genomics approaches to catalyze implementation of genomic medicine
• Identify and develop solutions for overcoming obstacles to genomic medicine implementation
• Create a global tool box for implementation of genomic medicine into practice

2nd G2MC Conference; November 6-7, 2015, Singapore – Implementing Genomic Medicine into Practice

The meeting objectives were to:

• Highlight nations or organizations around the world that are implementing genomic medicine into practice
• Foster/facilitate collaborations to enable the implementation of genomic medicine
• Highlight best practices and lessons learned to enable others to effectively implement genomic medicine approaches
• Identify and develop solutions for overcoming obstacles to genomic medicine implementation
• Identify and discuss regulations and policies that impact the implementation of genomic medicine
• Create a global tool box for implementation of genomic medicine into practice

1st G2MC Conference; January 8-9, 2014, Washington DC, USA – Global Leaders in Genomic Medicine

The goals of the meeting were to:

• Identify areas of active translational and implementation research, potential common strategies, and opportunities for collaborative efforts.
• Identify common barriers to implementation of genomics in healthcare and a policy agenda relevant to advances in the field.
• Identify nations with unique capabilities (such as national healthcare systems) that may allow rapid implementation and measures of key outcomes.
• Discuss opportunities (such as national healthcare system) that may allow rapid implementation and measures of key outcomes.

Welcome to Cape Town

Situated at the southern-most tip of the African Continent, the Western Cape is the number one destination in South Africa. Fondly referred to as the Africa’s Fairest Cape, this fourth largest Province in South Africa is blessed with incredible scenic beauty, unparallel botanical splendour and is, due to moderate climatic conditions, a year-round destination. 

The Province is home to Cape Town, where the world-renowned Table Mountain presides over Robben Island, place of incarceration of former President Nelson Mandela. It is within this region, representing the spirit of the South African nation, that visitors discover the soul of the country.

The Western Cape offers the visitor a unique cultural and natural heritage and a rural easy-going atmosphere, coupled with a first world Infrastructure. Has a mediterranean climate, many blue skies and wonderful friendly people. With its six distinct Regions, Cape Town Peninsula, Winelands, West Coast, Overberg, Garden Route, Karoo and Central Karoo, offers unparalleled beauty, a scintillating variety of experiences and value for money. It boasts some of the world’s most stunning tourist attractions, world-class accommodation, world-renowned restaurants, the famous V & A Waterfront, Robben Island and of course Table Mountain, Golf Courses and many entertainment venues. We are your one stop Information Centre when visiting Cape Town. Come and enjoy our Country.

 

Flights
Delegates are responsible for booking their own flights to and from Cape Town. In most cases, booking airline tickets via the internet is a cost-effective option.

 

Passport and Visas
As for all international travel, visitors to South Africa should be in possession of a valid passport. Passports must meet the following 2 requirements:

It should not be less than 6 months from the date of expiry.

There should be at least 1 full, free page in the passport for stamping by officials.

Citizens from countries that require visas for the Republic of South Africa (RSA), who arrive without visas, will be refused entry into the RSA and placed on return flights in terms of legislation.

Delegates are responsible for making their own visa arrangements. Travel agents and South African diplomatic missions will provide you with relevant information. Information and visa application forms can be found on the website of the South African Department of Home Affairs: www.dha.gov.za. Visas are not issued on arrival at South African ports of entry.

 

Health
Yellow fever vaccination is required for entry into South Africa from various countries in Central, East and West Africa – please confirm these requirements with the South African diplomatic mission in your country.

 

Attractions

Take time off to explore Table Mountain, V & A Waterfront, Cape Point, Robben Island, Kirstenbosch National Botanical Gardens, Boulders Beach Penguin Colony, Chapman’s Peak, Township life.  These are just the well-known sites to visit, but Cape Town has much more to offer.

 

Climate

Temperatures in November would range from an average 20°C minimum to 30°C maximum. Temperatures could reach 30°C with relatively high humidity. To visit the South African Weather Service, temperatures along the coast compare more favourably with those of the Mediterranean in summer (24°C), but in winter they seldom fall below (19°C) – 10° warmer than the Mediterranean in the same season.

 

Currency

The South African currency is the Rand (ZAR). The rate of exchange against international currencies is variable so foreign delegates are advised to check the daily published rates.

 

Insurance

Organising Committee cannot accept liability for personal injuries sustained, or for loss or damage of property belonging to participants or their accompanying persons. It is therefore recommended that delegates and accompanying persons arrange for appropriate travel and health insurance before traveling.

 

Language

South Africa has 11 official languages. English, however, is the first language and is spoken throughout the country.

 

Safety

While vigilance and common sense will ensure a trouble-free and enjoyable stay in South Africa, it is advisable to take the following precautions: do not leave luggage, mobile phones or valuables unattended; use the safety deposit boxes provided by most hotels; do not carry large amounts of cash, and keep cash, credit cards and identification documents in a secure place on your person.

 

Should you require any help planning your trip to Cape Town, contact Cape Town Tourism:

Phone: +27 (0)861 322 223 

Email: info@capetown.travel

Twitter: @CapeTownTourism

Venue of the 4th Global Genomic Medicine Collaborative Conference

The 4th Global Genomic Medicine Collaborative Conference will be held in the PRESIDENT hotel**** (4, Alexander Rd, Bantry Bay, Cape Town, 8001, South Africa).

Nestled beneath Bantry Bay’s majestic Lion’s Head, on the shores of the Atlantic Ocean and just a step away from Cape Town’s CBD, is the most beautiful urban resort in Cape Town. This award winning 4* luxury hotel combines contemporary sophistication and comfort with spaciousness, offering a world-class guest services and luxury facilities. The conference venues boast state-of-the-art infrastructure and the Wi-Fi offering is the fastest of any hotel in South Africa. The guests experience fresh sea air, panoramic ocean views, superb cuisine, unsurpassed service and a friendly team waiting to welcome them.

As the President Hotel is situated in Bantry Bay, which is known to be the most wind-free area in Cape Town, the hotel is secluded and protected and enjoys nearly 300 days of sunshine and wind free days per year.

Conference Organizing Committee

G2MC Co-Chairs 

Geoff Ginsburg; Director, Duke Center for Applied Genomics and Precision Medicine; Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA

Robyn Ward; Deputy Vice-Chancellor of Research, and Vice President of Research; The University of Queensland, Australia

George P. Patrinos; Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology and Head, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras, Department of Pharmacy, Patras Greece

Organizing Committee 

Co-Chairs

George P. Patrinos (Patras, Greece; Co-Chair)

Ambroise Wonkam (Cape Town, South Africa; Co-Chair)

Members

Vajira Dissanayake (Colombo, Sri Lanka)

Geoffrey Ginsburg (Durham, NC, USA)

Bruce Korf (Tuscallosa, AL, USA) 

Catalina Lopez-Correa (British Columbia, Canada)

Teri Manolio (Baltimore, MD, USA)

Raj Ramesar (Cape Town, South Africa)

Mandy Salomo (Cape Town, South Africa)

Robyn Ward (Queensland, Australia)

Grant Wood (Salt Lake City, UT, USA)

Young Investigators Forum Planning Committee

Teri Manolio (Baltimore, MD, USA; Co-Chair)

Ambroise Wonkam (Cape Town, South Africa)

Victoria Nembaware (Cape Town, South Africa)

Cedrik Ngongang (Yaounde, Cameroon)

George P. Patrinos (Patras, Greece)

Styliani Papadaki (Patras, Greece)

Keynote Speakers 

Vanessa Hayes (Sydney, Australia)

Dame Sue Hill (London, UK)

Farhad Imam (San Francisco, CA, USA)

Plenary Speakers 

Marc Abramowicz (Geneva, Switzerland)

Qais Al-Duwairi (Safat, Kuwait)

Pilar Carvallo (Santiago, Chile)

Collet Dandara (Cape Town, South Africa)

Vajira Dissanayake (Colombo, Sri Lanka)

Kelly East (Huntsville, AL, USA)

Ghada El-Kamah (Cairo, Egypt)

Karimah Es Sabar (Vancouver, Canada)

Geoffrey Ginsburg (Durham, NC, USA)

Rich Haspel (Boston, MA, USA)

Christian Happi Tientcha (Lagos, Nigeria)

Reinhard Hiller (Cape Town, South Africa)

Sula Hood (Indianapolis, USA)

Federico Innocenti (Chapel Hill, NC, USA)

Bruce Korf (Tuscallosa, AL, USA)

Judit Kumuthini (Cape Town, South Africa) 

Guida Landoure (Bamako, Mali)

Catalina Lopez-Correa (British Columbia, Canada)

Glaudina Loots (Cape Town, South Africa)

Surakameth Mahasirimongkol (Bangkok, Thailand)

Julie Makani (Dar Es Saalam, Tanzania)

Christina Mitropoulou (London, UK)

Leon Mutesa (Rwanda)

Nicola Mulder (Cape Town, South Africa)

Mohamed Nagy (Cairo, Egypt)

Gilles Ndayisaba (Rwanda)

Victoria Nembaware (Cape Town, South Africa)

George P. Patrinos (Patras, Greece)

Elissa Prichep (San Francisco, CA, USA)

Ratna Puri (New Delhi, India)

Jithesh Puthen (Doha, Qatar)

Alan Rabinovitz (Vancouver, Canada)

Martin Reese (Oakland, CA, USA)

Jurgen Reichardt (Quito, Ecuador)

Gabriela Repetto (Santiago, Chile)

Jean-Luc Sanne (Brussels, Belgium)

Fasil Tekola (Bethesda, MD, USA)

Nicki Tiffin (Cape Town, South Africa)

Scott Williams (Chicago, IL, USA)

Ambroise Wonkam (Cape Town, South Africa)

Grant Wood (Salt Lake City, UT, USA)

Yonglan Zheng (Chicago, IL, USA)

DAY 1: November 28, 2018

08:00 – 13:00   Registration (Location TBC)

Young Investigators Forum [President Ballroom)

08:00 – 08:05 Welcoming Remarks

Teri Manolio, Chair; YIF Planning Group, National Human Genome Research Institute, Baltimore, MD, USA 

08:05 – 10:50   Presentations from Young Investigators

10:50 – 11:10   Break

11:10 – 11:40   Career Development Session

Moderator: Teri Manolio (Baltimore, MD, USA)

Panel members: Victoria Nembaware (Cape Town, South Africa), Gabriela Repetto (Santiago, Chile), Surakameth Mahasirimongkol (Bangkok, Thailand), Cedric Ngongang (Cape Town, South Africa)

11:40 – 12:00   Young Investigator Flash Talks

12:00 – 13:30   Poster session and Lunch (Location: President Restaurant)

4th G2MC Conference – Main event 

13:30 – 13:45   Welcoming Remarks 

Glaudina Loots, Director; Department of Science and Technology (DST), Ministry of Science and Technology, South Africa

13:45 – 14:00   Welcoming Remarks  

G2MC Co-Chairs

Geoff Ginsburg; Director, Duke Center for Applied Genomics and Precision Medicine; Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA

George P. Patrinos; Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology and Head, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras, Department of Pharmacy, Patras Greece

14:00 – 14:05   Keynote introduction by George P. Patrinos

14:05 – 14:35   Keynote Lecture #1: Genome diversity in Africa: Lessons and application to genomic medicine

Vanessa Hayes, Professor; Garvan Institute of Medical Research University of Sydney, Australia

14:35 – 16:25  Session I: Genomic Medicine Implementation in Africa

Moderator: Ambroise Wonkam, University of Cape Town, South Africa 

Genomic Medicine in Africa: Promise Problems, Prospects

Ambroise Wonkam, University of Cape Town, South Africa

Neurogenomics in Mali

Guida Landoure,University of Bamako, Mali

Advancement of medical genetics and Genomic Medicine in Rwanda

Leon Mutesa, College of Medicine & Health Sciences, University of Rwanda, Rwanda

H3Africa Consortium and its potential role in African Genomic Medicine

Nicola Mulder, H3BioNet, University of Cape Town, South Africa

Development of Genomic Medicine in Egypt

Ghada El-Kamah, National Research Centre, Cairo, Egypt

Cancer Genomics Initiatives in Africa

Yonglan Zheng, University of Chicago, Chicago, Il, USA

16:25 – 17:05  Panel discussion

Moderator: Ambroise Wonkam

Panelists: Guida Landoure, Leon Mutesa, Nicola Mulder, Ghada El-Khamah, Yonglan Zheng

17:05 – 17:30  COFFEE BREAK

17:30 – 18:40  Session II: Genomic Medicine in the Developing World

Moderator: Catalina Lopez-Correa, Genome British Columbia, Canada

From emerging economies to first nations: Genomic Medicine for ALL

Catalina Lopez-Correa, Genome British Columbia, Quebec, Canada

Path towards an Innovation Economy

Karimah Es Sabar, Quark Venture, Vancouver, Canada

Genomic Medicine in Sri Lanka 

Vajira H. W. Dissanayake, University of Colombo, Sri Lanka

Genetics of breast cancer in Chilean women

Pilar Carvallo, Pontifical Catholic University of Chile, Chile

Rare Diseases in Latin America: Challenges and opportunities 

Gabriela Repetto, Universidad del Desarrollo, Chile

Reflections of a Biomedical Scientist on 4 Continents in Interdisciplinary Biomedical Research

Jurgen Reichardt, Yachay Tech University, San Miguel de Urcuqui, Ecuador

18:40 – 19:10  Panel discussion

Moderator: Catalina Lopez-Correa

Panelists: Juergen Reichardt, Vajira Dissanayake, Gabriela Repetto, Pilar Carvallo, Karimah Es Sabar, Qais Al-Duwairi

20:00                WELCOME COCKTAIL RECEPTION (President Hotel – Swimming Pool area)

Day 2: November 29, 2018

08:00 – 08:05  Keynote introduction by Geoff Ginsburg (Location: President Ballroom)

08:15 – 08:35  Keynote Lecture #2: A multiomics approach to identify predictive biomarkers and new biology for preterm birth and related newborn mortality contributors using cohorts from Africa and South Asia

Farhad Imam, Senior Program Supervisor, Bill & Melinda Gates Foundation, USA

08:35 – 10:05  Session III: Genotyping Cost-Effectiveness Across the World

Moderator: Nicola Mulder, University of Cape Town, South Africa

Precision Medicine in Thailand

Surakameth Mahasirimongkol, Ministry of Public Health, Thailand

Design of the H3Africa array for African populations

Nicola Mulder, H3BioNet, University of Cape Town, South Africa

Comparing cost-effectiveness of South Africa to the rest of the world

Reinhard Hiller, Center for Proteomic & Genomic Research, South Africa

Determining the value of pharmacogenomics evidence 

Christina Mitropoulou, The Golden Helix Foundation, London, UK 

09:45 – 10:15  Panel discussion

Moderator: Nicola Mulder

Panelists: Surakameth Mahisirimongkol, Reichardt Hiller, Christina Mitropoulou

10:15 – 10:45  BREAK

10:45 – 12:05  Session IV: Genomic Medicine and Infectious Diseases

Moderator: Raj Ramesar, University of Cape Town, South Africa

Genomics and the Control of Ebola Epidemic

Christian Happi Tientcha, Redeemer’s University, Nigeria

Genomics and Podoconiosis: Public Health translation to improve child health in a low-income setting

Fasil Tekola, National Institutes of Health (NIH), USA

Malaria and Sickle Cell Disease

Julie Makani, Muhimbili University, Dar Es Saalam, Tanzania

Co-evolution between mycobacterium and humans influences tuberculosis severity 

Scott Williams, Case Western Reserve, USA

Host genomics and upper respiratory diseases

Geoffrey Ginsburg, Duke University, USA

Microbiome of the placenta in pre-eclampsia

Vajira Dissanayake, University of Colombo, Sri Lanka

12:05 – 12:35  Panel discussion

Moderator: Raj Ramesar

Panelists: Christian Happi Tiehtcha, Fasil Tekola, Julie Makani, Scott Williams, Geoff Ginsbirg, Vajira Dissanayake

12:35 – 14:00  LUNCH BREAK (Location: President Restaurant)

Lunch meeting for Evidence Writing Group (Location: Boardroom)

Co-chairs: Marc Abramowicz (Geneva, Switzerland) and Fahd Al-Mulla (Safat, Kuwait)

14:00 – 15:30 Session V: Pharmacogenomics

Moderator: George P. Patrinos, University of Patras, Patras, Greece

Pharmacogenomics in Africa: Considerations for population health in transition

Collet Dandara, University of Cape Town, South Africa

Ubiquitous pharmacogenomics

George P. Patrinos, University of Patras, School of Health Sciences, Patras, Greece

The Alliance for clinical trials in oncology: A cooperative group to achieve precision oncology through genomics

Federico Innocenti, University of North Carolina at Chapel Hill, USA

Pharmacogenomics data standardisation and governance

Judit Kumuthini, Centre for Proteomics and Genomic Research, South Africa

Population Pharmacogenomics in the Middle East: A perspective from Qatar

Puthen Veettil Jithesh, Sidra Medical and Research Center, Qatar

Challenges of Clinical Pharmacogenomics Implementation and how to overcome

Mohamed Nagy, Children’s Cancer hospital, Cairo, Egypt 

A European Union perspective on Personalised Medicine 

Jean-Luc Sanne, European Commission, Brussels, Belgium

15:30 – 16:300  Panel discussion

Moderator: George P Patrinos

Panelists: Collet Dandara, Federico Innocenti, Judit Kumuthini, Put-on Veettil Jithesh, Mohamed Nagy, Jean-Luc Sanne 

16:00 – 16:30  Coffee break

16:30 – 17:45  Breakout Group Sessions

i. Education Working Group (President 1; Moderators: Vajira Dissanayake & Bruce Korf)

ii. Policy Working Group (Board Room; Moderators: Dame Sue Hill & Andrea Belcher)

iii. Pharmacogenomics Working Group: Clinical implementation (President 2; Moderator: George P. Patrinos)

iv: Pharmacogenomics Working Group: Evidence (President 3; Moderator: Federico Innocenti)

v. Pharmacogenomics Working Group: Policy (Suite TBC; Moderators: Puthen Veettil Jithesh, Mohamed Nagy)

19:00  Depart for Dinner (meet at hotel lobby)

19:30  DINNER (Gold Restaurant, 15 Bennett Street, Green Point, 8005)

Day 3: November 30, 2018

07:00 – 08:15  G2MC Steering Committee meeting (by invitation only; Location: President ballroom)

08:25 – 08:30  Keynote introduction by Alan Shuldiner 

08:30 – 09:00  Keynote Lecture #3: Title TBC 

Dame Sue Hill, Professor, National Health Service, London, UK

09:00 – 09:15  International Cohorts Summit

Geoff Ginsburg; Director, Duke Center for Applied Genomics and Precision Medicine; Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA

09:15 – 10:35  Session VI: Public Engagement in Genomic Medicine

Moderator: Grant Wood, Intermountain Precision Genomics, Intermountain Healthcare, USA

Linking genomic data with administrative health data in a low resource setting

Nicki Tiffin, University of Cape Town, Cape Town, South Africa

Family Health History Awareness: Tools for enhancing genetic literacy

Sula Hood, Indiana University-Purdue University Indianapolis, USA

Artificial-intelligence driven insights for genomic data interpretation in clinical care

Martin Reese, Fabric Genomics, USA

Inferring patient outcomes from the combination of genomic, phonemic and clinical data: A project proposal

Marc Abramovitz, Geneva University Hospitals (HUG), Geneva, Switzerland

Beyond the Heart Center: 21st century Medicine int he real world

Alan Rabinowitz, PHEMI Systems, University of British Columbia, Canada

Updates on HL7 FHIR Genomics and related activities

Grant Wood, Intermountain Precision Genomics, Intermountain Healthcare, USA

10:35 – 11:05  Audience discussion of the Health IT project ideas presented in this session

Moderated by Grant Wood

11:05 – 12:15  BREAK

12:15 – 13:25  Session VII: Professional Engagement and Workforce Development

Moderator: Vajira Dissanayake, University of Colombo, Sri Lanka& Bruce Korf, University of Alabama, USA

Genomic Medicine education of medical providers in India

Ratna Puri, Sir Ganga Ram Hospital, New Delhi, India

Competence and Community-Based Genomic Medicine Training in Africa

Victoria Nembaware, University of Cape Town, South Africa

Engaging healthcare providers in the practice of genomic medicine

Kelly East, HudsonAlpha Institute of Biotechnology, USA

The Genomic Medicine workforce: The global landscape 

Bruce Korf, University of Alabama, USA and Vajira Dissanayake, University of Colombo, Sri Lanka

Progress in the Inter-Society Coordinating Committee (ISCC) on Practitioner Education in Genomics

Rich Haspel, ISCC, Beth Israel Deaconess, USA 

13:25 – 13:55  Panel discussion

Moderators: Vajira Dissanayake & Bruce Korf, 

Panelists: Ratna Puri, Victoria Nembaware, Kelly East, Rich Haspel

13:55 – 14:55  Breakout Group Sessions Report

Moderator: Alan Shuldiner (Tarrytown, NY, USA)

i. Education Working Group (Moderators: Vajira Dissanayake & Bruce Korf)

ii. Policy Working Group (Moderators: Dame Sue Hill & Andrea Belcher)

iii. Pharmacogenomics Working Group: Clinical Implementation (Moderator: George P. Patrinos)

iv. Pharmacogenomics Working Group: Evidence (Moderator: Federico Innocenti)

v. Pharmacogenomics Working Group: Clinical Implementation (Moderators: Puthen Viittel Jithesh and Mohamed Nagy)

vi. Evidence Writing Group (Moderators: Marc Abramowicz & Fahd Al-Mulla)

14:55 – 15:20  Leapfrogging with Precision Medicine

Elissa Prichep, World Economic Forum

Gilles Ndayisaba, Rwanda Biomedical Centre, Rwanda

15:20 – 15:35  Poster Awards announcement

15:35 – 16:00  Closing remarks and Next Steps (from Co-Chairs of the meeting)

George P. Patrinos and Ambroise Wonkam

Geoff Ginsburg (on behalf of G2MC Co-Chairs)

16:00                MEETING ADJOURNS 

17:00 – 19:00  G2MC Executive Committee meeting (by invitation only) 

Sponsors

We are grateful to the following corporate entities for generously supporting this event.

Downloads